Home > Insider Trading > Filing (0001127430-17-000017)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1104506	Insmed Inc	INSM	Pharmaceutical Preparations (2834)	541972729

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1324734	T Andrew Drechsler	10 Finderne Avenue Building 10 Bridgewater NJ 08807	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-03-01	20,000	$6.65	25,000	No	4	M	Direct
Common Stock	Disposition	2017-03-01	20,000	$16.51	5,000	No	4	S	Direct
Common Stock	Acquisiton	2017-03-01	10,000	$6.65	15,000	No	4	M	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2017-03-01	20,000	$0.00	20,000	$6.65
Common Stock	Stock Option (right to buy)	Disposition	2017-03-01	10,000	$0.00	10,000	$6.65

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
74,855		2022-11-07	No	4	M	Direct
45,145		2022-11-07	No	4	M	Direct

Footnotes

The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.46 to $16.74, inclusive.
Stock options granted on November 7, 2012 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.